HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rui-Yan Zhang Selected Research

omega-Chloroacetophenone (Mace)

8/2015Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study.
4/2013Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study.
3/2013Improved outcomes from transradial over transfemoral access in primary percutaneous coronary intervention for patients with acute ST-segment elevation myocardial infarction and upstream use of tirofiban.
4/2010Absence of gender disparity in short-term clinical outcomes in patients with acute ST-segment elevation myocardial infarction undergoing sirolimus-eluting stent based primary coronary intervention: a report from Shanghai Acute Coronary Event (SACE) Registry.
3/2009Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study.
9/2008Long-term efficacy and safety of Chinese made sirolimus eluting stents: results, including off label usage, from two centres over three years.
11/2007[Clinical outcomes and safety of primary percutaneous coronary intervention combined with tirofiban therapy in patients with acute ST-segment elevation myocardial infarction].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rui-Yan Zhang Research Topics

Disease

7Thrombosis (Thrombus)
01/2018 - 09/2008
6Cardiovascular Diseases (Cardiovascular Disease)
08/2015 - 11/2007
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2024 - 09/2008
4ST Elevation Myocardial Infarction
03/2013 - 11/2007
3Myocardial Infarction
08/2015 - 03/2013
3Infarction (Infarctions)
03/2013 - 11/2007
2Coronary Disease (Coronary Heart Disease)
12/2022 - 03/2015
2Type 2 Diabetes Mellitus (MODY)
03/2015 - 01/2011
2Death (Near-Death Experience)
05/2013 - 04/2013
2Inflammation (Inflammations)
11/2012 - 01/2011
2Hyperplasia
11/2012 - 02/2010
1Atherosclerotic Plaque (Atheroma)
01/2024
1Multiple Organ Failure (MODS)
05/2022
1Chronic Kidney Failure (Chronic Renal Failure)
01/2021
1Chronic Renal Insufficiency
01/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2021
1Stroke (Strokes)
01/2018
1Heart Failure
01/2016
1Neoplasms (Cancer)
08/2015
1Stomach Neoplasms (Stomach Cancer)
08/2015
1Chest Pain (Chest Pains)
03/2015
1Pathologic Constriction (Stenosis)
03/2013
1Hemorrhage
03/2013
1Diabetes Mellitus
09/2008
1Stable Angina
09/2008
1Acute Coronary Syndrome
09/2008

Drug/Important Bio-Agent (IBA)

7omega-Chloroacetophenone (Mace)IBA
08/2015 - 11/2007
2Biomarkers (Surrogate Marker)IBA
01/2024 - 12/2022
2PolymersIBA
05/2013 - 11/2012
2Tirofiban (Aggrastat)FDA Link
03/2013 - 11/2007
2Sirolimus (Rapamycin)FDA Link
04/2010 - 09/2008
1RNA (Ribonucleic Acid)IBA
01/2024
1OsteopontinIBA
01/2024
1Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
12/2022
1NivolumabIBA
05/2022
1tyrosine O-sulfateIBA
01/2021
1Small Interfering RNA (siRNA)IBA
08/2015
1COP9 Signalosome ComplexIBA
08/2015
1FibrinIBA
03/2015
1estropipate (Ogen)FDA LinkGeneric
03/2015
1CreatinineIBA
03/2015
1LipidsIBA
03/2015
1formycin diphosphate (FDP)IBA
03/2015
1Fibrinogen (Factor I)FDA Link
03/2015
1C-Reactive ProteinIBA
03/2015
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
03/2015
1Glucose (Dextrose)FDA LinkGeneric
01/2011
1MetalsIBA
04/2010
1Clopidogrel (Plavix)FDA Link
09/2008
1FluvastatinFDA Link
09/2008
1Adenosine Diphosphate (ADP)IBA
09/2008
1Atorvastatin (Lipitor)FDA Link
09/2008
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2008
1Pravastatin (Pravachol)FDA LinkGeneric
09/2008

Therapy/Procedure

10Stents
01/2018 - 09/2008
5Percutaneous Coronary Intervention
03/2013 - 11/2007
4Therapeutics
01/2016 - 11/2007
1Thrombolytic Therapy
03/2009